Discover how Zydus Wellness is reinventing Complan, the iconic health drink, by expanding its target audience, leveraging digital commerce, and strengthening its scientific credibility to stay ...

Zydus Lifesciences receives USFDA approval for Methenamine Hippurate Tablets, strengthening position in US market.

Zydus Lifesciences said that it has received final approval from the United States Food and Drug Administration (US FDA) to manufacture Methenamine Hippurate Tablets.

Zydus will focus on state-of-the-art manufacturing capabilities that will enable high quality solutions for patients with cutting-edge research and innovation, reports Financial Express.

India's Zydus Lifesciences said on Tuesday it will acquire an 85.6% stake in France's Amplitude Surgical for 256.8 million ...